Úlceras por gota: Presentación de un caso y revisión de la literatura

dc.creatorHernández, José Ignacio
dc.creatorBonilla, Carlos Eduardo
dc.creatorLópez, José Fernando
dc.date.accessioned2004-06-01 00:00:00
dc.date.accessioned2022-02-21T20:35:37Z
dc.date.accessioned2022-09-27T12:38:48Z
dc.date.available2004-06-01 00:00:00
dc.date.available2022-02-21T20:35:37Z
dc.date.available2022-09-27T12:38:48Z
dc.date.created2004-06-01 00:00:00
dc.date.created2022-02-21T20:35:37Z
dc.date.issued2004-06-01
dc.identifier10.31260/RepertMedCir.v13.n2.2004.344
dc.identifier0121-7372
dc.identifierhttps://repositorio.fucsalud.edu.co/handle/001/2252
dc.identifier2462-991X
dc.identifierhttps://doi.org/10.31260/RepertMedCir.v13.n2.2004.344
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3596209
dc.languagespa
dc.publisherSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.relationGerstner, J. Glosario. Rev. Col. Ort Tra. 2002; 16.
dc.relationKramer HM, Curgan G The association between gout and nephrolithiasis: the nacional health and nutrition examination survey III, 1988-1994. Am. J Kidney Dis 2002; 4: 37-42
dc.relation3 Emmerson B, Word A. The Management of Gout. The N Engl J Med 1996; 334 (7): 446-51.
dc.relationCampion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia: risks and consequences in the Normative aging study. Am J Med 1987; 82: 421-26.
dc.relationLin KC, Lin HY, Chou P. Community based epidemiological study on hyperuricemia and gout. J Rheumatol 2000; 27: 1045-1050.
dc.relationWaller PC, Ramsay LE. Predicting acute gout in diuretic - treated hypertensive patients. J Hum Hypertens 1989; 3: 457-61.
dc.relationKelley ' s Reumatologia. Sinovitis por depósito de Cristales. Gota e hiperuricemia. 2003, Madrid, España: v.3 p.1339-76.
dc.relationBulla F, Restrepo J F, Iglesias A., Palma, F. Paniculitis por gota. Rev Col Reum 2000:7 (4): 391-95.
dc.relationWortmann RL. Gout and Hyperuricemia. Curr Opin Rheumatol 2002; 14:281-86.
dc.relationSchlesinger N, Schumacher HR Jr. Gout: can management be improved?. Curr Opin Rheumatol 2001; 13:240-44.
dc.relationDurán R, Altahona H, Hernández J.I, Barreto F.J. Seminarios en Medicina Interna. Bogotá; Universidad del Rosario, 1995; 420.
dc.relationWallace SL, et al. Preliminary criteria for the classiflcation of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895-900.
dc.relationTerkeltaub R A Gout. N. Engl J Med 2003, 349 (17): 1647-55.
dc.relationTerkeltaub RA. Pathogenesis and treatment of crystal induced inflammation. In: Koopman WJ, ed. Arthritis and allied conditions: a textbook of Rheumatology. 14 th ed. Philadelphia: Lippincot Williams & Wilkins, 2001; v 2; p. 2329-47.
dc.relationSchlesinger N, Detry MA, Holland BK et al. Local ice therapy during bouts of acute gouty arthritis. J Rheumatol 2002; 29:331-34.
dc.relationAxelrod D, Preston S. Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout. Arthritis Rheum 1988; 31:803-05.
dc.relationSiegel LB, Alloway JA, Nashel DJ. Comparison of adrenocorticotropic hormone and triamcinolone acetinide in the treatment of acute gouty arthritis. J Rheumatol 1994; 21:1325-27.
dc.relationEmmerson, B. The Management of Gout. N England J Med 1996; 334 (7): 445-51.
dc.relationFerraz MB. An evidence based appraisal of the management of nontophaceous interval gout. J Rheumatol 1995; 22: 1618-19.
dc.relationInsel P. Analgésicos - Antipiréticos, antiinflamatorios y fármacos Antigotosos. En: Goodman & Gilman's Las Bases Farmacológicas de la Terapéutica,. 9' ed. McGraw-Hill Interamericana. v. 1 p 661-705.
dc.relationPérez-Ruiz F, Calabozo M, Pijoan JI, Herrero AM, RUibal A. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 2002; 47:356-60.
dc.relationShahinfar S, Simpson RL, Carides AD et al. S afety of losartan in hypertensive patients with thiazide-induced hyperuricemia. Kidney Int 1999;56:1879-85.
dc.relationSica DA, Schoolwerth AC. Uric Acid and losartan. Curr Opin Nephrol Hypertens 2002; 11:475-82.
dc.relationWurzner G, Gerster JC, Chiolero A, et al. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout. J Hypertens 2001; 19 (10):1855-60.
dc.relationBomalaski JS, Holtsberg FW, Ensor CM, Clark MA. Uricase formulated with poyetiethylene glycol (Uricase-PEG 20): biochemical rationale and preclinical studies. J Rheumatol 2002; 29:1942-49.
dc.relationHepburn AL, Kaye SA, Fcher Fenofibrate: a new treatment for hyperuricaemia and gout?. Ann Rheum Dis 2001; 60(10):984-6.
dc.relationYamamoto T, Moriwaki Y, Takahashi S, et al. Effect of fenofibrate on plasma concentration and urinary excretion of purine bases and oxypurinol. J Rheumatol. 2001; 28 (10): 229497.
dc.relationHardin T. Fenofibrate and losartan. Ann Rheum Dis, 2003; 62 (6): 497-98.
dc.relationHepbumAL, Feher Gout. N Engl J Med, 2004; 350 (5): 519-20.
dc.relationNiemi, K M. Panniculitis of the legs with urate cristal deposition. Archi Dermatol 1977; 113: 655-6.
dc.relationLe Boit PE, Schneider S. Gout presenting as lobular panniculitis. Am. J Dermatopathol. 1987; 9:334-38.
dc.relationConejo-M J, Pulpillo, A et al. Panniculitis and ulcers in a young man. Arch Dermatol 1998; 134: 499-504.
dc.relationhttps://revistas.fucsalud.edu.co/index.php/repertorio/article/download/344/372
dc.relationNúm. 2 , Año 2004 : Abril – Junio
dc.relation66
dc.relation2
dc.relation61
dc.relation13
dc.relationRevista Repertorio de Medicina y Cirugía
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rightsFundación Universitaria de Ciencias de la Salud FUCS - 0
dc.sourcehttps://revistas.fucsalud.edu.co/index.php/repertorio/article/view/344
dc.titleÚlceras por gota: Presentación de un caso y revisión de la literatura
dc.typeArtículo de revista
dc.typeJournal article


Este ítem pertenece a la siguiente institución